References

British Association of Dermatologists, National Eczema Society. National Eczema Society and British Association of Dermatologists joint position statement on Topical Steroid Withdrawal. 2021. https//cdn.bad.org.uk/uploads/2022/04/12091607/Position-statement-on-Topical-Steroid-Withdrawal.pdf (accessed 10 August 2023)

De Lusignan S, Alexander H, Broderick C The epidemiology of eczema in children and adults in England: A population-based study using primary care data. Clin Exp Allergy. 2021; 51:471-482 https://doi.org/10.1111/cea.13784

Greenwell K, Ghio D, Muller I Taking charge of eczema self-management: a qualitative interview study with young people with eczema. BMJ Open. 2021; 11 https://doi.org/10.1136/bmjopen-2020-044005

Lawton S. Childhood Atopic Eczema: Adherence to treatment. Nurse Prescribing. 2014; 12:5:226-231

Everything you need to know about managing childhood eczema. 2022. http//www.allergyuk.org/wp-content/uploads/2023/04/Everything-you-need-to-know-about-Eczema.pdf (accessed 10 August 2023)

Lawton S Eczema Care Online – a new evidence-based resource to support people with eczema. Dermatological Nursing. 2023; 2:(91)62-68

Margolis JS, Abuabara K, Bilker W, Hoffstad O, Margolis DJ. Persistence of Mild to Moderate Atopic Dermatitis. JAMA Dermatol. 2014; 150:(6)593-600 https://doi.org/10.1001/jamadermatol.2013.10271

Medicines and Healthcare products Regulatory Agency. Herbal products: safety update. 2014. https//www.gov.uk/drug-safety-update/herbal-products-safety-update (accessed 10 August 2023)

Medicines and Healthcare products Regulatory Agency. Topical steroid withdrawal reactions: a review of the evidence. 2021. http//www.gov.uk/government/publications/topical-steroid-withdrawal-reactions-a-review-of-the-evidence/topical-steroid-withdrawal-reactions-a-review-of-the-evidence (accessed 10 August 2023)

National Institute for Health and Care Excellence. Eczema – atopic. 2023. https//cks.nice.org.uk/topics/eczema-atopic/ (accessed 10 August 2023)

National Institute for Health and Care Excellence. QS44: Quality standard on Atopic eczema in children. 2013. http//www.nice.org.uk/guidance/QS44 (accessed 10 August 2023)

National Institute for Health and Care Research School for Primary Care Research. Navigating primary care with Topical Corticosteroid Withdrawal (TSW). 2023. http//www.spcr.nihr.ac.uk/research/projects/navigating-primary-care-with-topical-corticosteroid-withdrawal-tsw (accessed 10 August 2023)

Powell K, Le Roux E, Banks JP, Ridd MJ. Developing a written action plan for children with eczema: a qualitative study. Br J Gen Pract. 2018; 68:(667)e81-e89 https://doi.org/10.3399/bjgp17X693617

Ridd MJ, King AJL, Le Roux E, Waldecker W, Huntley AL. Systematic review of self-management interventions for people with eczema. British Journal of Dermatology. 2017; 177:(3)719-734 https://doi.org/10.1111/bjd.15601

Santer M, Burgess H, Yardley L, Ersser S, Lewis-Jones S, Muller I, Hugh C, Little P. Experiences of carers managing childhood eczema and their views on its treatment: qualitative study. British Journal of General Practice. 2012; 62:192-193

Santer M, Muller I, Becque T, Stuart B, Hooper J, Steele M Eczema Care Online behavioural interventions to support self-care for children and young people: two independent, pragmatic, randomised controlled trials. BMJ. 2022; 379 https://doi.org/10.1136/bmj-2022-072007

Thandi C, Vincent R, Ridd MR. Written action plans to support the self-management of eczema: findings from an international review. British Journal of Dermatology. 2021; 185:(51)135-135

Supporting children, young people and families with eczema

02 November 2023
Volume 5 · Issue 11

Abstract

Eczema is a complex disease to self-manage, between tackling the flares, following a regular maintenance regimen and avoiding triggers. It also has an impact on all aspects of life of infants, children, young people and their families, from self-esteem to relationships, education and social activities, mainly due to persistent itching and pain, sleep disturbance and emotional distress. Effective treatment of eczema demands good self-management which, if established early on, can lead to considerable improvements in quality of life and adherence to an agreed plan.

Eczema (also known as atopic eczema, childhood eczema and atopic dermatitis) is a common dry, itchy skin condition that usually develops in early childhood, affecting 15–30% of children (Thandi et al, 2021). Around 70–90% of cases occur before 5 years of age, with a high incidence of onset in the first year of life, which may improve or resolve by late childhood (National Institute for Health and Care Excellence (NICE), 2023), although it may persist in adolescence and adulthood (Margolis et al, 2014). There are considerable differences in eczema incidence and prevalence by ethnicity, socio-demographic characteristics and geography, demonstrating the need to consider these factors when assessing health needs (De Lusignan et al, 2021).

Effective treatment of eczema demands good self-management which, if established early on, can lead to considerable improvements in quality of life (Ridd et al, 2017). Self-management can be particularly challenging during adolescence and early adulthood, and young people must take on a more active role in their eczema management, a role that was previously the primary responsibility of their families (Greenwell et al, 2021). The right education, guidance, support and self-management tools are crucial.

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month